| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |